Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Diamedica Therapeutics Inc (DMA.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 55,360
  • Shares Outstanding, K 11,957
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 2.78
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 31.03
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.79
  • Most Recent Earnings -0.07 on 09/30/18
  • Next Earnings Date 11/26/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.330 +39.04%
on 12/20/18
5.050 -8.32%
on 01/10/19
+0.730 (+18.72%)
since 12/18/18
3-Month
3.330 +39.04%
on 12/20/18
11.000 -57.91%
on 10/19/18
-5.970 (-56.32%)
since 10/18/18
52-Week
3.330 +39.04%
on 12/20/18
18.000 -74.28%
on 07/13/18
-1.370 (-22.83%)
since 01/18/18

Most Recent Stories

More News
DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease

DiaMedica Therapeutics Inc. ("DiaMedica") (NASDAQ:DMAC) (TSX-V:DMA) announced today that the U.S. Food and Drug Administration ("FDA") has accepted DiaMedica's Investigational New Drug application ("IND")...

DMA.VN : 4.630 (-2.11%)
DMAC : 3.95 (+18.26%)
DMCAF : 0.3840 (+0.52%)
DiaMedica Closes Public Offering in the United States

DiaMedica Therapeutics Inc. ("DiaMedica" or the "Company") (NASDAQ:DMAC; TSXV:DMA), a clinical stage biopharmaceutical company, announced today that it has completed an underwritten initial public offering...

DMA.VN : 4.630 (-2.11%)
DMCAF : 0.3840 (+0.52%)
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 21.13 (-3.65%)
NGVC : 11.93 (-3.40%)
STC : 42.70 (+0.47%)
ATUS : 21.37 (-3.91%)
RBA : 33.35 (-1.39%)
MHK : 124.86 (-2.56%)
NVCR : 47.04 (-5.92%)
CVSI : 5.7100 (+5.16%)
AC : 38.79 (-3.29%)
BSX : 37.30 (-2.23%)
HON : 155.83 (-1.65%)
POTND : 0.0200 (+32.45%)
PRTT : 1.3000 (-4.62%)
TARSD : 0.2033 (-1.64%)
NKE : 82.19 (-6.61%)
ROIC : 16.89 (-1.05%)
DGX : 89.24 (-0.42%)
EIX : 64.69 (-0.45%)
GARLF : 0.0700 (-0.14%)
MRNA : 19.00 (-1.76%)
MSPC : 0.0002 (unch)
RYAAY : 71.46 (-2.55%)
BA : 362.17 (-2.83%)
BDC : 53.64 (-7.04%)
BC : 49.73 (-4.24%)
OXFD : 17.54 (-2.45%)
NDAQ : 83.89 (-0.55%)
TTOO : 2.91 (unch)
DMAC : 3.95 (+18.26%)
CMCM : 6.77 (-3.56%)
ALGN : 269.62 (-3.96%)
ABM : 33.88 (-3.09%)
RTN : 179.99 (-1.07%)
IESC : 17.43 (-2.95%)
KIDS : 44.55 (-4.30%)
CYL.VN : 0.150 (+3.45%)
FLIR : 47.54 (-2.56%)
NETC.CN : 0.095 (unch)
SLCA : 16.02 (-5.65%)
BANX : 21.89 (+4.34%)
APOG : 35.22 (-2.57%)
RBBN : 5.02 (-4.02%)
SPLIF : 0.2070 (-3.72%)
SO : 51.88 (+0.60%)
SNWV : 0.1849 (+12.06%)
ACB : 9.03 (-5.64%)
CE : 98.14 (-4.42%)
QILFF : 0.3927 (+17.79%)
QILFD : 0.2331 (-29.98%)
MANH : 54.08 (-4.13%)
MKL : 984.51 (-0.59%)
HAL : 28.73 (-4.36%)
LZB : 31.61 (-3.30%)
INTC : 53.26 (-2.53%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,764.77 (-3.00%)
ACHC : 30.06 (-3.72%)
TX : 26.97 (-4.09%)
SRPT : 122.26 (-3.47%)
JOUT : 66.76 (-4.36%)
CCAN : 0.2210 (-4.12%)
OBMP : 0.0096 (unch)
ELY : 15.76 (-5.35%)
DY : 46.94 (-4.94%)
HIPH : 0.0410 (-9.89%)
POTN : 0.1520 (+3.40%)
JWN : 42.93 (-1.90%)
SYF : 31.83 (-3.28%)
AQUA : 12.71 (-4.51%)
NWVCF : 1.3480 (-1.56%)
USYNF : 2.5900 (+0.60%)
EMR : 66.86 (-3.47%)
BXE : 0.46 (-3.16%)
HSY : 112.00 (+0.45%)
EW : 188.99 (-1.64%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 17.97 (+0.50%)
PSX : 95.98 (-2.61%)
MVIS : 0.98 (-1.42%)
PCI : 23.58 (-1.42%)
PCN : 17.23 (+0.12%)
AVT : 42.12 (-4.45%)
MGNX : 18.98 (-4.24%)
ICBK : 16.80 (-4.55%)
DLR : 119.12 (-0.24%)
RHI : 63.73 (-3.98%)
YVR : 3.60 (-6.99%)
PTY : 17.30 (-0.97%)
PDI : 32.10 (-1.20%)
TNXP : 2.32 (-7.57%)
GBT : 49.51 (-5.71%)
QI.VN : 0.290 (-27.50%)
TSRO : 74.96 (+0.03%)
RHP : 82.66 (-1.54%)
NKTR : 32.17 (-3.91%)
GOOG : 1,205.50 (-2.11%)
JBLU : 15.93 (-2.27%)
IGC : 2.20 (+11.11%)
WBT : 15.70 (-3.80%)
WRY.VN : 0.100 (+66.67%)
SAPIF : 33.1800 (-0.39%)
WSO : 137.24 (-2.75%)
LMT : 294.01 (-1.67%)
CMCSA : 39.46 (-1.47%)
HSDT : 6.80 (+3.03%)
GWRE : 93.59 (-2.76%)
CLGX : 35.94 (-1.07%)
FNSR : 22.86 (-2.60%)
SONS : 7.83 (+2.76%)
DEWM : 0.0010 (unch)
SLG : 89.72 (-1.34%)
UPS : 107.35 (-2.23%)
PFN : 10.45 (unch)
KMB : 122.05 (+0.49%)
ANZ.VN : 0.075 (unch)
TAOP : 1.01 (-0.98%)
NSU : 4.44 (-0.22%)
CBDS : 2.9100 (-3.00%)
CTXS : 100.46 (-1.22%)
PCOM : 13.39 (+0.07%)
HTHT : 39.00 (-1.84%)
MAN : 80.75 (-5.94%)
CNK : 39.84 (-0.10%)
AMAT : 39.86 (-3.56%)
FMCC : 2.4700 (-2.37%)
MRK : 82.29 (-0.80%)
ATOS : 3.68 (-1.34%)
WTCRF : 0.0138 (unch)
MLRKF : 0.0617 (-10.58%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 57.72 (-4.41%)
COOL : 17.33 (-0.69%)
SAVE : 53.05 (-1.74%)
PCRX : 38.22 (-3.85%)
RNLSY : 12.9850 (-4.59%)
COL : 141.04 (-0.42%)
COR : 105.12 (-1.89%)
IDXG : 0.85 (-3.54%)
MCD : 186.81 (+0.24%)
ETST : 0.7000 (-2.64%)
QNIIF : 0.5410 (-8.31%)
PII : 79.58 (-3.75%)
AMRS : 2.26 (-18.71%)
SON : 59.30 (-1.61%)
MCK : 118.54 (-3.02%)
APHA : 9.53 (-5.27%)
MCO : 177.89 (-2.25%)
GSKY : 12.86 (-4.95%)
LH : 154.32 (-1.27%)
SAP.TO : 44.64 (-0.73%)
ODFL : 142.72 (-2.13%)
NEU : 428.31 (-1.99%)
ORTX : 16.85 (-0.88%)
BXE.TO : 0.57 (-1.72%)
GWPRF : 13.7600 (-3.78%)
PZN : 8.02 (-2.43%)
RBX.VN : 0.080 (+6.67%)
RNG : 106.59 (-4.46%)
SPG : 177.60 (-0.33%)
TRVN : 1.70 (+1.19%)
AMC : 15.06 (-2.33%)
UTX : 125.15 (-1.36%)
AMD : 26.37 (-5.45%)
NDLS : 6.61 (-2.22%)
MPWR : 139.67 (-3.68%)
KGKG : 0.0805 (+4.14%)
FRO-UN.VN : 0.540 (-1.82%)
DMCAF : 0.3840 (+0.52%)
IRMTF : 11.9721 (-0.40%)
BOX : 19.07 (-4.41%)
IQST : 1.1000 (-54.17%)
ASPS : 24.37 (-7.16%)
HMNY : 0.0120 (+6.19%)
ROP : 329.47 (-1.36%)
GOVB : 12.6000 (-3.08%)
PKO : 26.35 (-0.97%)
MYGN : 33.10 (-1.25%)
CRL : 141.03 (-3.88%)
GLPH : 0.0300 (+36.36%)
BXXRF : 0.0102 (+100.00%)
ADTN : 14.04 (-4.16%)
GRNH : 0.0182 (unch)
NS : 26.97 (-2.35%)
LTS : 2.82 (-3.75%)
INT : 28.92 (-5.43%)
INPX : 1.11 (-5.93%)
GSPT : 0.0400 (unch)
MRO.VN : 0.090 (-5.26%)
COST : 237.56 (-0.83%)
EFX : 112.88 (-1.84%)
BMRN : 88.05 (-3.01%)
SPGI : 205.49 (-2.04%)
IGCC : 2.7600 (+44.50%)
PYPL : 101.27 (-2.77%)
LHSIF : 0.7100 (+0.72%)
TDY : 227.61 (-3.98%)
AZPN : 102.52 (-3.30%)
ENW.VN : 1.800 (-1.10%)
DMA.VN : 4.630 (-2.11%)
SNAP : 10.73 (-2.54%)
KSU : 112.46 (-3.48%)
MERC : 13.59 (-3.82%)
DVA : 54.05 (-1.73%)
UNI.VN : 3.700 (-0.27%)
MGI : 2.14 (-4.89%)
IGAP : 0.2700 (unch)
FIT : 5.83 (-3.80%)
RAD : 0.67 (-2.99%)
LDSR : 0.0022 (-4.35%)
CYLYF : 0.1100 (+4.46%)
PMX : 12.50 (+0.64%)
ROBXF : 0.0001 (unch)
BRO : 28.88 (-0.79%)
DiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney Disease

-- DiaMedica preparing to submit an IND to initiate DM199 clinical study in patients with chronic kidney disease in the US

DMA.VN : 4.630 (-2.11%)
DMCAF : 0.3840 (+0.52%)
DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer

DiaMedica Therapeutics Inc. (the "Company") (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the appointment of Mr. Scott Kellen as Chief Financial Officer and Corporate Secretary.

DMA.VN : 4.630 (-2.11%)
DMCAF : 0.3840 (+0.52%)
DiaMedica to Present at the MicroCap Conference on April 10th in New York City at the Essex House

MINNEAPOLIS, MN / ACCESSWIRE / April 3, 2018 / DiaMedica Therapeutics Inc. (''DiaMedica'') (TSX-V: DMA) (OTCQB: DMCAF), today announced that Mr. Rick Pauls, President and CEO, will present at The MicroCap...

DMA.VN : 4.630 (-2.11%)
DMCAF : 0.3840 (+0.52%)
DiaMedica Therapeutics Announces Final Closing of Private Placement

DiaMedica Therapeutics Inc. (the "Company" and "DiaMedica") (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the second and final tranche of its previously announced offering...

DMA.VN : 4.630 (-2.11%)
DMCAF : 0.3840 (+0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 5.037
1st Resistance Point 4.833
Last Price 4.630
1st Support Level 4.493
2nd Support Level 4.357

See More

52-Week High 18.000
Fibonacci 61.8% 12.396
Fibonacci 50% 10.665
Fibonacci 38.2% 8.934
Last Price 4.630
52-Week Low 3.330

See More

Business Summary

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. It is principally engaged in the business activity of developing treatments for unmet clinical need or where no therapies are available with a primary focus on neurological and kidney diseases. Its pipeline products include DM300,...

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar